GLP-1 pioneer Lotte Bjerre Knudsen says the food industry needs to listen
FT Weekend sits down with Lotte Bjerre Knudsen, a key scientist behind GLP-1 drugs, who has a message for food makers.
Recap by typeshit. Post by FT Weekend on X.
FT Weekend sits down with Lotte Bjerre Knudsen, a key scientist behind GLP-1 drugs, who has a message for food makers.
Recap by typeshit. Post by FT Weekend on X.
Tara Wider has spent about five years posting on holistic beauty and women's wellness, building a following of women her age on social media.
Brown says diet and exercise still matter, but argues that shaming people for treating obesity with medication has never made anyone healthier.
A short share on growing GLP-1 use in the US, with no figures or sources attached. Thin on detail beyond the headline itself.
A new survey covered by Chain Store Age tracks how GLP-1 users are shifting their food spending from restaurants toward grocery stores.
He says this average comes from his own clinical experience, adding that some strong responders drop more than 10 kg. A personal observation, not trial data.
An Annals of Oncology study of about 230,000 adults with obesity linked GLP-1 use to fewer obesity-related cancers, though it can't show the drugs caused it.
Loading…